HealthcareDEPLOYAnnounced
Dr. Reddy’s and Takeda signed pact for private-market distribution of QDENGA in India
Hyderabad, Telangana· company base18 Sept 2026
Dr. Reddy’s Laboratories entered into an exclusive distribution agreement with Takeda Pharmaceutical Company to promote and distribute Takeda’s dengue vaccine QDENGA in India’s private market for pediatric and adult vaccination. The article says the vaccine had received CDSCO marketing authorisation in July 2026 and is expected to be available in India in the first half of 2027, subject to local regulatory processes.
Why it matters
This agreement sets up a commercial distribution channel for an approved dengue vaccine in India’s private market, which can enable access once supply becomes available.
Dr. Reddy's LaboratoriesTakeda Pharmaceutical Company